RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
This cost-effective tool will be of immense benefit to other high burden countries as well.
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
In clinical trials, treatment proved more effective than other therapies evaluated
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Subscribe To Our Newsletter & Stay Updated
